Nexalin appeals Nasdaq delisting notice after failing $1 minimum bid requirement
NXL•Nasdaq delisting notice and appeal
Nexalin Technology faces Nasdaq delisting after failing to regain compliance with the $1 minimum bid price rule by July 20, 2026.
Nasdaq set a suspension date of Aug. 4, 2026, with a Form 25-NSE filing to remove the shares from listing.
The company is ineligible for a second compliance period because it does not meet Nasdaq’s $5 million minimum stockholders’ equity initial listing requirement.
A timely appeal request triggers a stay of the suspension pending a Nasdaq Hearings Panel decision.
The compliance plan may include a reverse stock split to restore the minimum bid price.
Related News
Ocean Power Technologies enters at-the-market equity offering agreement for up to $20 million stock sale
OPTT•
Kymera Therapeutics files initial beneficial ownership statement for Chief Medical Officer Terence Rooney
KYMR•
